glp-1 brain inflammation for Weight Loss and Diabetes Glucagon-like peptide-1 suppresses neuroinflammation and

Of the currently available classes of glucose-lowering therapies, the glucagonlike peptide-1 (GLP-1) receptor agonist class of medications has gained popularity in recent years

This represents a much larger reduction compared to the 26 percent reduction observed in male GLP-1 users compared to the male control group

10 GLP-1 receptor agonists (GLP-1RAs), or incretin mimetics, are currently among the most promising drugs for adjusting metabolic function, playing significant roles in the management of T2DM, and some have been approved for obesity management

Our most popular weight loss treatment

Neuron 39(6):889909